Hyponatremia and Extracellular Fluid in Cirrhotic

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hyponatremia and Extracellular Fluid in Cirrhotic trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedPhase 4

NCT01552590

Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites

This study is to evaluate the efficacy of a 2-week course of tolvaptan in improving serum sodium and the excretion of extracellular fluid in liver cirrhotic pat…

South Korea74 participantsStarted 2012-04

Treatment: Tolvaptan, Placebo